Does Anti Thymocyte Globulin Interact with Belatacept?
Anti Thymocyte Globulin and Belatacept have a major drug interaction according to U.S. FDA drug labeling data. Coadministration of anti-thymocyte globulin and belatacept in de novo kidney transplant recipients may pose risk for venous thrombosis of the renal allograft, especially in patients with predisposing risk factors. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Belatacept Class
- Selective T Cell Costimulation Blocker
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
What To Tell Your Doctor or Pharmacist
If you are taking Anti Thymocyte Globulin and your doctor is considering prescribing Belatacept (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider